Victories Against AIDS Have Lessons for COVID-19
Anthony Fauci on four decades of progress against HIV, and what's needed for the future.
Send us a link
Anthony Fauci on four decades of progress against HIV, and what's needed for the future.
Researchers are racing to determine whether a fast-spreading variant in South Africa poses a threat to COVID vaccines' effectiveness.
Flights from six countries will be banned as officials review travel measures after scientists voice concern over variant.
The former president of the European Research Council (ERC) is sounding an alarm that the COVID-19 pandemic may disrupt Europe's supply of scientific talent.
This is the first scientometric study of the performance of social science research on COVID-19. It provides insight into the landscape, the research fields, and international collaboration in this domain. The results are useful for finding potential collaborators and for identifying the frontier and gaps in social science research on COVID-19 to shape future studies.
Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials.
The emergence of the novel SARS-CoV-2 coronavirus and the global COVID-19 pandemic in 2019 led to explosive growth in scientific research. Given the high stakes of the situation, it is essential that scientific findings, on which good policy depends, are as robust as possible; as the empirical example shows, reproducibility is one of the keys to ensure this.
A COVID-19 commission must be created by the U.S. government, experts argue in the latest issue of Science. Members of Obama's PCAST offer recommendations for such a commission to examine to prepare for future pandemics.
Part 2 of this series looking at open access developments in Canada examines the changing processes and infrastructure needs for open science.
A look at open access policies and developments in Canada, especially in light of the Covid-19 pandemic. Part 1 of a 2 part post.
Survey of 3,500 supervisors lifts the lid on the demands of overseeing junior researchers - and the impacts of the pandemic.
Surveys show that women, parents of young children and people of colour are most affected by pandemic-related disruptions and need more support.
Puerto Rico has an underfunded health care system, high levels of poverty and its infrastructure remains devastated by a major hurricane that swept through the island in 2017.
At first, no one looked twice at the new variant. Detected in South Africa in January 2021, the novel coronavirus lineage, called C.1, appeared similar to other variants.
In a bid to stave off looming disaster, scientists are trying to repurpose drugs used for malaria and other diseases, but infrastructure and recruitment challenges hinder progress.
An international team of researchers wants to find people who are genetically resistant to SARS-CoV-2, in the hope of developing new drugs and treatments.
The pandemic has caused disruption to many aspects of scientific research. In this Comment the authors describe the findings from surveys of scientists between April 2020 and January 2021, which suggests there was a decline in new projects started in that time.
The mystery of COVID's origins has reignited a contentious debate about potentially risky studies and the fuzzy terminology that describes them.
The Global Preparedness Monitoring Board is calling for a coherent action plan to counter future health emergencies
Kids under 12 years generally can't get a COVID vaccine. US authorities will rule on emergency approval for the BioNTech-Pfizer jab for 5- to 11-year-olds.
To combat COVID and future pandemics, governments need to heed the lessons of social interventions and not just the technological ones.
Rather than causing a backlash, vaccine mandates promote vaccination uptake, according to research from the University of Pennsylvania.
Experts warn findings do not prove cholesterol-lowering drugs can reduce death rates.
Largest study of its kind also finds vaccines appear to protect against worst effects of Delta variant
Without Ian MacLachlan’s innovative delivery system, Moderna and Pfizer couldn’t safely get their mRNA vaccines into your cells. So why does hardly anyone acknowledge the Canadian biochemist’s seminal contributions - or pay a dime in royalties?